TrialResearch and practice in thrombosis and haemostasis2026

Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.

Masahiro Takeyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.